NewsRoom Articles - Page 104 of 112

TuesdayFeb 20, 2018 12:07 pm

Liberty Leaf Holdings Ltd. (CSE: LIB) (OTCQB: LIBFF) (FSE: HN3P) is “One to Watch”

Vertically-integrated cannabis company with two late-stage ACMPR licenses in portfolio Strategic investments focus on proven, revenue-generating cannabis-related businesses Liberty Leaf is included in the Solactive Emerging Marijuana Growers Index Liberty Leaf Holdings Ltd. (CSE: LIB) (OTCQB: LIBFF) (FSE: HN3P) is a publicly traded Canadian-based company with strategic investments in businesses that are established, revenue- producing players in the medicinal and recreational cannabis market. Liberty Leaf’s focus is to build and support a diversified portfolio of cannabis-sector businesses, including those involved in the cultivation and processing of legal medicinal and recreational cannabis, value-added CBD/THC pet products, and supply-chain products for this…

ThursdayFeb 15, 2018 4:11 pm

Global Hemp Group Inc. (CSE: GHG) (FRA: GHG) (OTC: GBHPF) Aims to be a Leader in the Multi-Faceted Industrial Hemp Market

Industrial hemp is the only commodity that has the potential to generate revenue from multiple finished goods in the global food, construction materials, nutraceutical, textile and bio-energy industries Global Hemp Group completed hemp trials last year which set the stage for a full-fledged commercial hemp operation in New Brunswick, Canada, in 2018 Under Canadian law, CBD will become legal to extract from Industrial Hemp in July 2018 Hemp Business Journal estimates that the hemp industry will grow to $1.8 billion in sales by 2020, led by hemp food, body care, and CBD-based products Official data demonstrates that the hemp industry…

ThursdayFeb 15, 2018 3:21 pm

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP): IP Portfolio, Licensing and R&D are Keys to Growth in 2018

LXRP has global patents or patents-pending in more than 40 countries, including the U.S., Australia, China, the European Union and Canada Company is working through a C$250,000 budget for an 18-month collaborative research agreement with the National Research Council Licensing is a revenue generator, with LXRP offering to license its disruptive DehydraTECH™ technology in countries where it is patented or patent-pending Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) is generating revenue and knowledge through both licensing of its IP portfolio and advancement of R&D projects. It already has patents and multiple patents-pending in more than 40 countries. It has received…

WednesdayFeb 14, 2018 3:41 pm

Pivot Pharmaceuticals Inc. (PVOTF) Provides Update Covering Recent Achievements and Activities

Update highlights proposed acquisitions, product development and growing IP portfolio Three new patent filings join established global rights to other patented technologies Innovative transdermal delivery technology increases bioavailability of cannabinoids Global cannabis market projected to reach $31.4 billion by 2021 Pivot Pharmaceuticals Inc. (OTCQB: PVOTF) has provided investors an update covering a number of recent achievements and ongoing activities, including the company’s proposed acquisitions of ERS Holdings, LLC and Thrudermic, LLC; its ongoing product development efforts; its growing IP portfolio; its termination of a previously announced standstill agreement; out-licensing of its IP; and its engagement of an established European distribution…

TuesdayFeb 13, 2018 2:19 pm

Strategic Partnerships Elevate The Green Organic Dutchman’s Premium Cannabis To Heady Future

Closing of $112 million in private placement financing fully funds expansion plans Time-to-market accelerated as Aurora Cannabis inks strategic investment/partnership with TGOD Highly anticipated IPO scheduled for March 2018 Organic, medical-grade cannabis grown at low cost increases profit margins The Green Organic Dutchman Holdings Ltd. (“TGOD”) continues to make headlines as it forms strategic partnerships and banks investment funds to fuel the company’s expansion plans to become the largest organic cannabis company in the world. The company’s recent announcement of its closing of $112 million in private placement financing included a cornerstone investment of $55 million by marijuana industry powerhouse…

MondayFeb 12, 2018 11:53 am

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Expanding Best-in-Class Product Line

Lexaria has developed an oral digestion technology that may translate into lower dosages and shorter treatment regimens Company is expanding its edible product offerings through a licensing agreement with a Canadian cannabis chocolate manufacturer Lexaria continues to develop products for demonstration, testing and sales Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) has developed DehydraTECH™, an oral digestion technology believed to improve the absorption rates of nicotine, non-steroid anti-inflammatory drugs (NSAIDs), vitamins and cannabinoids by as much as five to ten times the normal rate. The time of onset is also reduced, and effects are felt within 15 to 20 minutes…

FridayFeb 02, 2018 2:37 pm

Global Hemp Group, Inc. (CSE: GHG) (FRANKFURT: GHG) (OTC: GBHPF) is “One to Watch”

U.S. hemp retail market estimated at $1.8 billion by 2020 with 22% CAGR Global hemp-based cannabidiol (CBD) segment projected to reach $3 billion by 2021 Disruptive potential for industrial hemp products offers substantial rewards Global Hemp Group, Inc. (CSE: GHG) (FRANKFURT: GHG) (OTC: GBHPF), headquartered in British Columbia, Canada, is a publicly traded company founded in 2014. Global Hemp Group is focused on acquiring and developing a strategic portfolio of like-minded companies that believe in the significant potential of the industrial hemp plant. Global Hemp Group’s focused on attracting joint venture partners across all sectors of the industrial hemp industries…

FridayFeb 02, 2018 12:28 pm

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Enters Agreement with Cannabis-Infused Edibles Manufacturer

Lexaria enters agreement with Cannfections to develop an innovative range of cannabis-infused chocolates and gummies incorporating its proprietary technology, DehydraTECH™ Cannfection’s formulation and manufacturing expertise can be offered to other Lexaria licensee partners The agreement is expected to generate new cannabis-based edible products for domestic and international markets On January 25, 2018, Lexaria Bioscience Corp. (OTCQX: LXRP) (CSE: LXX) announced that it had entered into a seven-year agreement with Cannfections Group Inc. to provide its patented DehydraTECH™ technology for the development of a new range of cannabis-infused chocolates and gummies (http://cnw.fm/Hef3A). Cannfections is a new company, established by one of…

FridayFeb 02, 2018 9:39 am

Sunniva, Inc. (CSE: SNN) Begins Trading on the Canadian Stock Exchange

SNN is a vertically integrated medial cannabis company operating in California and Canada Company's goal is to increase shareholder value by boosting stock liquidity and increasing exposure to investors SNN has a number of subsidiaries, including Sunniva Medical, Inc., CP Logistics, LLC, Natural Health Services Ltd., and Full Scale Distributors, LLC Sunniva, Inc., (CSE: SNN) began trading on the Canadian Stock Exchange under the ticker symbol "SNN" in early January, it announced (http://cnw.fm/hT2WM). The company is a North American provider of medical cannabis products and services. SNN is a vertically integrated medical cannabis company operating in California and Canada, both…

ThursdayFeb 01, 2018 3:58 pm

Pivot Pharmaceuticals Inc. (PVOTF) is “One to Watch”

Transdermal cannabis-based therapy promises greater absorption, less side effects Global medical marijuana market projected to reach $55.8 billion U.S. by 2025 Novel CBD delivery method targets array of unmet healthcare needs Pivot Pharmaceuticals Inc. (OTCQB: PVOTF), based in Vancouver, Canada, is an emerging biopharmaceutical company engaged in the development and commercialization of pharmaceuticals and nutraceuticals that provide novel treatments for unmet healthcare needs. Pivot’s recent acquisition of BiPhasix ™ Transdermal Drug Delivery technology for the delivery of cannabinoids (CBD) to patients provides the answer for an age-old problem associated with cannabinoid-based therapies: the lack of a robust smoke-less delivery mechanism.…

News and Publishing Service for Cannabis Related, Canadian Companies

Contact us: 905.674.5977